Oncotarget · 2016 · 45 citations · 27 references
MedicineOncologyPathologyMetastasisMolecular OncologyTumor HeterogeneityCancer Molecular PathologyCirculating Tumor CellsColorectal CancerLiver MetastasisMalignant NeoplasmsTumor HistopathologyCirculating Tumor Cell CharacterizationCirculating Tumor Cell DisseminationCirculating Tumor Cell Metastatic PotentialCirculating Tumor Cell Molecular ProfilingColorectal Cancer PathologyColorectal Liver MetastasisMetastatic Liver TumorsPrimary Tumor Characterization
// Wendy Onstenk 1 , Anieta M. Sieuwerts 1 , Bianca Mostert 1 , Zarina Lalmahomed 2 , Joan B. Bolt-de Vries 1 , Anne van Galen 1 , Marcel Smid 1 , Jaco Kraan 1 , Mai Van 1 , Vanja de Weerd 1 , Raquel Ramírez-Moreno 1 , Katharina Biermann 3 , Cornelis Verhoef 2 , Dirk J. Grünhagen 2 , Jan N.M. IJzermans 2 , Jan W. Gratama 1 , John W.M. Martens 1 , John A. Foekens 1 , Stefan Sleijfer 1 1 Erasmus MC Cancer Institute, Department of Medical Oncology and Cancer Genomics Netherlands, Rotterdam, The Netherlands 2 Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands 3 Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands Correspondence to: Wendy Onstenk, email: w.onstenk@erasmusmc.nl Keywords: circulating tumor cells, CTCs, CellSearch, colorectal cancer, gene expression profiling Received: April 06, 2016     Accepted: May 29, 2016     Published: June 20, 2016 ABSTRACT Background: CTCs are a promising alternative for metastatic tissue biopsies for use in precision medicine approaches. We investigated to what extent the molecular characteristics of circulating tumor cells (CTCs) resemble the liver metastasis and/or the primary tumor from patients with metastatic colorectal cancer (mCRC). Results: The CTC profiles were concordant with the liver metastasis in 17/23 patients (74%) and with the primary tumor in 13 patients (57%). The CTCs better resembled the liver metastasis in 13 patients (57%), and the primary tumor in five patients (22%). The strength of the correlations was not associated with clinical parameters. Nine genes ( CDH1 , CDH17 , CDX1 , CEACAM5 , FABP1 , FCGBP , IGFBP3 , IGFBP4 , and MAPT ) displayed significant differential expressions, all of which were downregulated, in CTCs compared to the tissues in the 23 patients. Patients and Methods: Patients were retrospectively selected from a prospective study. Using the CellSearch System, CTCs were enumerated and isolated just prior to liver metastasectomy. A panel of 25 CTC-specific genes was measured by RT-qPCR in matching CTCs, primary tumors, and liver metastases. Spearman correlation coefficients were calculated and considered as continuous variables with r=1 representing absolute concordance and r=-1 representing absolute discordance. A cut-off of r>0.1 was applied in order to consider profiles to be concordant. Conclusions: In the majority of the patients, CTCs reflected the molecular characteristics of metastatic cells better than the primary tumors. Genes involved in cell adhesion and epithelial-to-mesenchymal transition were downregulated in the CTCs. Our results support the use of CTC characterization as a liquid biopsy for precision medicine.
27
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu, Aditya Bardia, Ben S. Wittner et al. · Science · 2013 · 2.5K citations
Medicine, Cell Biology, Oncology +12
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Sandra Misale, Rona Yaeger, Sebastijan Hobor et al. · Nature · 2012 · 1.9K citations · Full text
Steven J. Cohen, Cornelis J.A. Punt, Nicholas Iannotti et al. · Journal of Clinical Oncology · 2008 · 1.8K citations · Full text